Xerium Technologies (XRM) 18.58 $XRM 27.1% Return Seen

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 7:57 PM

Xerium Technologies (XRM) 18.58 $XRM

27.1% Return Seen to Date on SmarTrend Xerium Technologies Call (XRM)
Comtex SmarTrend(R) - Wed Apr 22, 9:22AM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on August 15th, 2014 at $14.44. In approximately 8 months, Xerium Technologies has returned 27.08% as of today's recent price of $18.35.
XRM: 18.58 (+0.19)

Xerium Schedules First Quarter 2015 Conference Call
Business Wire - Tue Apr 21, 3:30PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, today announced that it plans to release its financial results for the first quarter of 2015 after the close of regular market trading on Monday, May 11, 2015.
XRM: 18.58 (+0.19)

Xerium Launches Innovative SMART(R) Technology for Suction Roll Applications on Tissue and Paper Machines
Business Wire - Fri Apr 17, 3:30PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, recently launched SMART(R) Technology engineered especially for vacuum assisted suction roll applications on tissue and paper machines. This newly developed functionality for the company's patented SMART(R) Technology platform provides tissue, paper and paperboard manufacturers unprecedented real-time diagnostics and production optimization data for their suction roll press positions. More information about SMART(R) Technology is available on our website at http://www.xerium.com/news/xerium-news.aspx.
XRM: 18.58 (+0.19)

Xerium Technologies Up 24.3% Since SmarTrend Uptrend Call (XRM)
Comtex SmarTrend(R) - Tue Apr 14, 5:01PM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on August 15th, 2014 at $14.44. In approximately 8 months, Xerium Technologies has returned 24.31% as of today's recent price of $17.95.
XRM: 18.58 (+0.19)

Xerium To Present Four Technical Papers at PaperCon 2015 Exhibition and Conference in Atlanta, Georgia
Business Wire - Tue Apr 14, 3:33PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, announced it will present 4 technical papers at the PaperCon 2015 Exhibition and Conference. This event, held in Atlanta, Georgia April 19-22, 2015, is North America's most comprehensive paper industry event of the year, providing the latest industry trends and advancements as well as extensive networking opportunities throughout various management ranks. Xerium's papers will highlight several technological advancements in machine clothing, rolls and analytical tools, and will demonstrate how customers are applying them to reduce cost and improve productivity. The PaperCon 2015 event details are available at: www.papercon.org.
XRM: 18.58 (+0.19)

Xerium launches Huydura family of de-watering wires for pulp production presses
M2 - Wed Apr 08, 4:23AM CDT
Xerium Technologies Inc (NYSE:XRM), a provider of industrial consumable products and services, revealed on Wednesday the recent launch of the Huydura family of de-watering wire technology for twin wire presses and double wire presses for pulp production.
XRM: 18.58 (+0.19)

Xerium Expands Huydura Family of Dewatering Wires for Twin Wire Presses and Double Wire Presses
Business Wire - Tue Apr 07, 3:30PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, recently launched the Huydura family of dewatering wire technology for twin wire presses and double wire presses for pulp production. The innovative Huydura portfolio now includes three product tiers providing the industry's most advanced pulp-making wire technology. Huydura AP, Huydura HD, and Huydura XL are specially engineered to provide optimum dewatering, sheet release, and durability at the highest pressure loads. Huydura is also available in endless and seamed versions for the most demanding applications. Learn more about Huydura technology at http://www.xerium.com/news/xerium-news.aspx.
XRM: 18.58 (+0.19)

Xerium Asia Pacific Qualified to do Business as a Regional Operation Center in the China Pilot Free Trade Zone
Business Wire - Tue Apr 07, 3:20PM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services announced that it's 100% owned subsidiary Xerium Asia Pacific (Shanghai) Limited ("Xerium Asia Pacific"

recently qualified to do business as a Regional Operation Center in the China (Shanghai) Pilot Free Trade Zone, joining a select group of qualifying companies. This is beneficial to Xerium from multiple angles, including (1) improving financial flexibility by more effectively managing its global cash and liquidity, (2) gaining the ability to access regional financial markets, and (3) reducing order lead times as a result of its strong customs rating and expedited customs clearance.
XRM: 18.58 (+0.19)

Xerium Technologies Up 18.6% Since SmarTrend Uptrend Call (XRM)
Comtex SmarTrend(R) - Tue Apr 07, 11:45AM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on August 15th, 2014 at $14.44. In approximately 8 months, Xerium Technologies has returned 18.56% as of today's recent price of $17.12.
XRM: 18.58 (+0.19)

Xerium Technologies Has Returned 11.8% Since SmarTrend Recommendation (XRM)
Comtex SmarTrend(R) - Mon Mar 30, 5:05PM CDT
SmarTrend identified an Uptrend for Xerium Technologies (NYSE:XRM) on August 15th, 2014 at $14.44. In approximately 8 months, Xerium Technologies has returned 11.84% as of today's recent price of $16.15.
XRM: 18.58 (+0.19)

Xerium To Present Technical Paper at Tissue World 2015 in Barcelona, Spain
Business Wire - Wed Mar 11, 7:30AM CDT
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, announced that Bill Butterfield, executive vice president and chief technology officer, will be presenting a technical paper at this year's Tissue World Barcelona on March 17, 2015.
XRM: 18.58 (+0.19)

Xerium Technologies (XRM) Harold C. Bevis on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 04, 7:15PM CST

XRM: 18.58 (+0.19)

Xerium EPS of $0.72
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 5:07AM CST

XRM: 18.58 (+0.19)

InsiderInsights.com Daily Round Up 2/24/15: TRUE, NS, D, HOS
InsiderInsights - at Seeking Alpha - Wed Feb 25, 9:17AM CST

72.52 (+0.43), TIME: 22.64 (+0.07), STFC: 23.83 (-0.01), ANET: 66.27 (+0.40), VR: 42.62 (+0.27), XRM: 18.58 (+0.19), MCHP: 49.30 (+0.08), NS: 65.49 (+1.78), USCR: 35.73 (-0.28), GOOG: 539.36 (+5.39), IBTX: 38.80 (+0.34), MAS: 26.85 (+0.50), HOS: 20.11 (-0.89), AGTC: 20.02 (-1.41), QSR: 39.36 (+0.67), CUDA: 45.71 (-0.08), TRUE: 15.72 (-0.26), PPG: 226.40 (-0.65), CAP: 24.54 (-0.22)

Xerium Schedules Fourth Quarter and Year-End 2014 Conference Call
GlobeNewswire - Fri Feb 06, 3:39PM CST
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, today announced that it plans to release its financial results for the fourth quarter and full year of 2014 after the close of regular market trading on Tuesday, March 3, 2015.
XRM: 18.58 (+0.19)

Xerium Announces Analyst Coverage Initiated by Macquarie Capital
GlobeNewswire - Wed Feb 04, 3:36PM CST
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, is pleased to announce that Macquarie Capital has initiated analyst coverage on Xerium.
XRM: 18.58 (+0.19)

Equities Lead Investor Sentiments: New Research on Westlake, Westlake Chemical Partners, Xerium, Xinyuan and Yamana
PR Newswire - Thu Jan 15, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Westlake (NYSE: WLK), Westlake Chemical Partners (NYSE: WLKP), Xerium (NYSE: XRM), Xinyuan (NYSE: XIN), and Yamana (NYSE: AUY). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
WLK: 75.87 (+0.16), WLKP: 28.44 (-0.01), XRM: 18.58 (+0.19), XIN: 3.34 (+0.09), AUY: 3.83 (-0.15)

Xerium Announces Two Plant Expansion Projects in Roll Cover and Mechanical Services Business
GlobeNewswire - Wed Jan 14, 3:01PM CST
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, announced two plant expansion projects to enhance its rolls products and mechanical services capabilities for the North American market.
XRM: 18.58 (+0.19)

Xerium to Present at Sidoti Institutional Investor Forum January 12, 2015
GlobeNewswire - Mon Jan 05, 3:39PM CST
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, today announced that Harold Bevis, President and CEO; Cliff Pietrafitta, Chief Financial Officer and David Pretty, President, Xerium North America and Europe will present at the Sidoti & Company Emerging Growth Institutional Investor Forum on Monday, January 12, 2015 at 9:20 AM Eastern Time at The Grand Hyatt Hotel in New York City.
XRM: 18.58 (+0.19)

Xerium Named by Triangle Business Journal as One of the Top 35 Healthiest Employers for 2014
GlobeNewswire - Mon Dec 29, 9:30AM CST
Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, recently was honored by Triangle Business Journal as one of the top 35 Healthiest Employers for 2014.
XRM: 18.58 (+0.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...